ROYAL BANK OF CANADA - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$43,000
+53.6%
5,866
+84.3%
0.00%
Q2 2023$28,000
+600.0%
3,182
+650.5%
0.00%
Q1 2023$4,000
+33.3%
424
+45.7%
0.00%
Q4 2022$3,000291
+1978.6%
0.00%
Q3 2022$0
-100.0%
14
-94.9%
0.00%
Q2 2022$2,000
+100.0%
273
+145.9%
0.00%
Q1 2022$1,000111
+552.9%
0.00%
Q4 2021$0
-100.0%
17
-81.9%
0.00%
Q3 2021$1,000
-66.7%
94
-77.2%
0.00%
Q2 2021$3,000
-76.9%
413
-80.4%
0.00%
Q1 2021$13,000
+44.4%
2,111
+75.2%
0.00%
Q4 2020$9,000
+800.0%
1,205
+625.9%
0.00%
Q3 2020$1,000
-75.0%
166
-66.2%
0.00%
Q2 2020$4,000491
+1344.1%
0.00%
Q1 2020$034
-55.8%
0.00%
Q4 2019$0
-100.0%
77
-90.4%
0.00%
Q3 2019$4,000
+300.0%
805
+170.1%
0.00%
Q2 2019$1,0000.0%298
+46.8%
0.00%
Q1 2019$1,000
-66.7%
203
-59.5%
0.00%
Q4 2018$3,000
-62.5%
501
-46.6%
0.00%
Q3 2018$8,000
+700.0%
938
+1259.4%
0.00%
Q2 2018$1,000690.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders